Our mission is to become a transnational pharmaceutical company through the development and introduction of a wide portfolio of branded and generic products in key markets.
Press Releases
|
Financial News
|
Archives
Archives
*
Lupin Receives US FDA Approval for Cephalexin Oral Suspension.
18 Aug'05
*
Lupin Pharmaceuticals, Inc. and Cornerstone BioPharma,Inc. Enter Co-Promotion Agreement for Suprax®
27 Jan'05
*
Lupin Launches Branded Finished Dosage in the US Sets up Pediatric Sales Force
06 Apr'04
*
Lupin Enters into Collaboration to Promote Zymar to Pediatricians in the U.S.
29 Mar'04
*
Lupin enters into an alliance with Baxter for Ceftriaxone
28 Feb'04
*
Lupin receives USFDA approval for Cefixime Suspension
24 Feb'04
*
Lupin receives USFDA approval for Cefixime Tablets
13 Feb'04
*
Lupin receives USFDA approval for Ceftriaxone Sterile Vials for Injection
01 Oct'03
*
Lupin receives USFDA approval for Cefotaxime Sterile Vials for Injection
25 Sep'03
*
Lupin receives USFDA approval for Cefuroxime Axetil Tablets
28 Jul'03
*
Lupin files ANDAs for Ceftriaxone and Cefotaxime
16 Apr'03
Copyright © 2006. All rights reserved.
Created and Designed by
GM